Ventana Biotech, Inc.
VNTA · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $1 | $1 | $19 |
| % Growth | 0% | 0% | -95.8% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $19 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 0% | 0% | 0% | 0% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $4 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $4 | $9 |
| Operating Income | -$1 | -$2 | -$4 | $10 |
| % Margin | -104.4% | -199.6% | -445.6% | 53.9% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | -$1 | -$2 | -$4 | $10 |
| Tax Expense | $0 | $0 | $1 | $0 |
| Net Income | -$1 | -$2 | -$4 | $10 |
| % Margin | -104.4% | -199.6% | -554.6% | 53.9% |
| EPS | 0 | 0 | -0 | 0 |
| % Growth | – | 100% | -150% | – |
| EPS Diluted | 0 | 0 | -0 | 0 |
| Weighted Avg Shares Out | 53,784 | 53,784 | 53,783 | 53,783 |
| Weighted Avg Shares Out Dil | 53,784 | 53,784 | 53,783 | 53,783 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$1 | -$2 | -$4 | $10 |
| % Margin | -104.4% | -199.6% | -445.6% | 53.9% |